XBiotech (XBIT) Non-Current Deffered Revenue (2015 - 2018)
XBiotech (XBIT) posted quarterly Non-Current Deffered Revenue of $3000.0 for Q4 2018, down 83.33% year-over-year from $18000.0 in Q4 2017, and down 57.14% quarter-over-quarter from $7000.0 in Q3 2018.
XBiotech (XBIT) Non-Current Deffered Revenue (2015 - 2018) Analysis & Trends
XBiotech's Non-Current Deffered Revenue history runs 4 years deep, the most recent figure standing at $3000.0 for Q4 2018.
- In Q4 2018, Non-Current Deffered Revenue fell 83.33% year-over-year to $3000.0; the TTM figure through Dec 2018 stood at $3000.0 (down 83.33% YoY), while the FY2018 annual figure was $3000.0, down 83.33% from the prior year.
- Non-Current Deffered Revenue for Q4 2018 stood at $3000.0, down from $7000.0 in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $23000.0 in Q4 2016, with the low at $2000.0 in Q1 2015.
- The 4-year median for Non-Current Deffered Revenue is $17500.0 (2015), against an average of $15312.5.
- The sharpest annual moves came in 2016 and 2018: Non-Current Deffered Revenue jumped 900.0% in 2016, then slumped 83.33% in 2018.
- XBiotech's Non-Current Deffered Revenue stood at $17000.0 in 2015, then soared by 35.29% to $23000.0 in 2016, then fell by 21.74% to $18000.0 in 2017, then plunged by 83.33% to $3000.0 in 2018.
- Business Quant data shows XBIT's Non-Current Deffered Revenue at $3000.0 in Q4 2018, $7000.0 in Q3 2018, and $12000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 220.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 147.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | XBiotech | 69.51 Mn | 69.51 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 3,000.00 |
| Sep 30, 2018 | 7,000.00 |
| Jun 30, 2018 | 12,000.00 |
| Mar 31, 2018 | 16,000.00 |
| Dec 31, 2017 | 18,000.00 |
| Sep 30, 2017 | 20,000.00 |
| Jun 30, 2017 | 22,000.00 |
| Mar 31, 2017 | 23,000.00 |
| Dec 31, 2016 | 23,000.00 |
| Sep 30, 2016 | 22,000.00 |
| Jun 30, 2016 | 21,000.00 |
| Mar 31, 2016 | 20,000.00 |
| Dec 31, 2015 | 17,000.00 |
| Sep 30, 2015 | 12,000.00 |
| Jun 30, 2015 | 7,000.00 |
| Mar 31, 2015 | 2,000.00 |